Cargando…
The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis
BACKGROUND: MCM3AP antisense RNA 1 (MCM3AP-AS1) is a newly identified potential tumor biomarker. Nevertheless, the prognostic value of MCM3AP-AS1 in cancer has been inconsistent in the available studies. We performed this meta-analysis to identify the prognostic role of MCM3AP-AS1 in various cancers...
Autores principales: | Fu, Liangyin, Zhang, Guangming, Wang, Yongfeng, Lu, Tingting, Liu, Bin, Jiao, Yajun, Ma, Haizhong, Ma, Shixun, Yang, Kehu, Cai, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249515/ https://www.ncbi.nlm.nih.gov/pubmed/35783010 http://dx.doi.org/10.1155/2022/4466776 |
Ejemplares similares
-
Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis
por: Liu, Bin, et al.
Publicado: (2022) -
MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
por: Yu, Xiao, et al.
Publicado: (2021) -
FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta−Analysis and Bioinformatics Analysis
por: Zhang, Guangming, et al.
Publicado: (2022) -
Clinicopathological Significance and Prognostic Values of Long Noncoding RNA BCYRN1 in Cancer Patients: A Meta-Analysis and Bioinformatics Analysis
por: Han, Xiaoyong, et al.
Publicado: (2022) -
A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers
por: Zhang, Guangming, et al.
Publicado: (2022)